403
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Treatment of Chronic, Noninfectious, Nonnecrotizing Scleritis with Tumor Necrosis Factor Alpha Inhibitors

, BS, , MD, PhD, , BS, , MD & , MD
Pages 469-477 | Received 18 Aug 2013, Accepted 05 Nov 2013, Published online: 19 Dec 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Jaime E. Brown, Akshay S. Thomas, Karen R. Armbrust, Kelly Boyd, Meghan Berkenstock & Laura J. Kopplin. (2023) Therapeutic Outcomes of Non-Infectious Scleritis Treated with Tumor Necrosis Factor-Alpha Inhibitors. Ocular Immunology and Inflammation 0:0, pages 1-7.
Read now
Albert Liao, Caroline Fajoles-Vasseneix, Aditya Rali, Laura Ward, Alcides Fernandes, Purnima S. Patel, Ghazala O’Keefe, Jessica G. Shantha & Steven Yeh. (2023) Visual Morbidity and Outcomes of Scleritis Associated with Intraocular Inflammation Compared to Isolated Scleritis. Ocular Immunology and Inflammation 0:0, pages 1-8.
Read now
Carla Gaggiano, Virginia Berlengiero, Antonio Vitale, Maria Tarsia, Salvatore Grosso, Gian Marco Tosi, Francesca Ricci, Jurgen Sota, Valeria Caggiano, Bruno Frediani, Luca Cantarini, Marco Cattalini & Claudia Fabiani. (2022) The Role of Biologic Agents in the Management of Pediatric-Onset Noninfectious Posterior Scleritis. Ocular Immunology and Inflammation 0:0, pages 1-7.
Read now
Melis Kabaalioğlu Güner, Ankur Mehra & Wendy M. Smith. (2021) Novel strategies for the diagnosis and treatment of scleritis. Expert Review of Ophthalmology 16:6, pages 431-448.
Read now
C. Bottin, A. Fel, N. Butel, F. Domont, A. L. Remond, L. Savey, V. Touitou, J. F. Alexandra, P. LeHoang, P. Cacoub, B. Bodaghi & D. Saadoun. (2018) Anakinra in the Treatment of Patients with Refractory Scleritis: A Pilot Study. Ocular Immunology and Inflammation 26:6, pages 915-920.
Read now
Lauren A. Sielert, Alexander R. Harris, John M. Pyun, Brett J. Campbell & Robert T. Swan. (2016) Posterior scleritis. Expert Review of Ophthalmology 11:6, pages 475-484.
Read now
Merih Oray, Halea Meese & C. Stephen Foster. (2016) Diagnosis and management of non-infectious immune-mediated scleritis: current status and future prospects. Expert Review of Clinical Immunology 12:8, pages 827-837.
Read now
Rupesh Agrawal, Cecilia S. Lee, Julio J. Gonzalez-Lopez, Sharmina Khan, Valeria Rodrigues & Carlos Pavesio. (2016) Flurbiprofen: A Nonselective Cyclooxygenase (COX) Inhibitor for Treatment of Noninfectious, Non-necrotizing Anterior Scleritis. Ocular Immunology and Inflammation 24:1, pages 35-42.
Read now

Articles from other publishers (22)

Alejandra de-la-Torre, Mariana Cabrera-Pérez, Claudia Durán, Sandra García, Miguel Cuevas, Néstor Carreño, Carlos M. Rangel, Diana Isabel Pachón-Suárez, María Alejandra Martínez-Ceballos, María Elisa Mejía, Alejandra Gómez-Rocha, Camilo Andrés Gómez-Durán, Yanny Pérez, Juliana Reyes-Guanes, Carlos Cifuentes-González & William Rojas-Carabali. (2022) Clinical patterns and risk factors in scleritis: a multicentric study in Colombia. Graefe's Archive for Clinical and Experimental Ophthalmology 260:12, pages 3957-3967.
Crossref
Binyao Chen, Shizhao Yang, Lei Zhu, Xuening Peng, Daquan He, Tianyu Tao & Wenru Su. (2022) Adalimumab plus Conventional Therapy versus Conventional Therapy in Refractory Non-Infectious Scleritis. Journal of Clinical Medicine 11:22, pages 6686.
Crossref
Yasemin Fatma ÇETİNKAYA. (2022) Ocular Findings in Rheumatoid Arthritis: Retrospective StudyRomatoid Artritte Göz Bulguları: Retrospektif Çalışma. Konuralp Tıp Dergisi 14:3, pages 481-485.
Crossref
Ahmad Abdel-Aty, Akash Gupta, Lucian Del Priore & Ninani Kombo. (2022) Management of noninfectious scleritis. Therapeutic Advances in Ophthalmology 14, pages 251584142110708.
Crossref
Nandini Venkateswaran, Jordan Ueberroth, Victor L. Perez & Charles Stephen Foster. 2022. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology 857 900 .
Yusuke Nishio, Hiroko Taniguchi, Ayaka Takeda & Junko Hori. (2021) Immunopathological Analysis of a Mouse Model of Arthritis-Associated Scleritis and Implications for Molecular Targeted Therapy for Severe Scleritis. International Journal of Molecular Sciences 23:1, pages 341.
Crossref
Ji Wen, Huifang Hu, Menglin Chen, Hang Yang, Yi Zhao & Yi Liu. (2021) Role of Janus Kinase (JAK) Inhibitor in Autoimmune Ocular Inflammation: A Systematic Review. Journal of Immunology Research 2021, pages 1-9.
Crossref
Jurgen Sota, Matteo-Maria Girolamo, Bruno Frediani, Gian Marco Tosi, Luca Cantarini & Claudia Fabiani. (2021) Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review. Ophthalmology and Therapy 10:4, pages 777-813.
Crossref
Srilakshmi M Sharma, Erika Damato, Ann E Hinchcliffe, Colm D Andrews, Katie Myint, Richard Lee & Andrew D Dick. (2021) Long-term efficacy and tolerability of TNFα inhibitors in the treatment of non-infectious ocular inflammation: an 8-year prospective surveillance study. British Journal of Ophthalmology 105:9, pages 1256-1262.
Crossref
Raul E. Ruiz-Lozano, Lucas A. Garza-Garza, Osvaldo Davila-Cavazos, C. Stephen Foster & Alejandro Rodriguez-Garcia. (2021) The clinical and pathogenic spectrum of surgically-induced scleral necrosis: A review. Survey of Ophthalmology 66:4, pages 594-611.
Crossref
Nandini Venkateswaran, Jordan Ueberroth, Victor Perez & C. Stephen Foster. 2020. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology 1 45 .
Yingnan Gao, Liping Du, Fuzhen Li, Jiadong Ding, Geng Li, Qingfeng Cao, Na Li, Guannan Su, Aize Kijlstra & Peizeng Yang. (2020) The haplotypes of various TNF related genes associated with scleritis in Chinese Han. Human Genomics 14:1.
Crossref
Claudia Fabiani, Jurgen Sota, Maite Sainz-de-la-Maza, Laura Pelegrín, Giacomo Emmi, Giuseppe Lopalco, Florenzo Iannone, Lorenzo Vannozzi, Silvana Guerriero, Maria Chiara Gelmi, Donato Rigante, Gian Marco Tosi, José Hernández-Rodríguez & Luca Cantarini. (2020) New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy. Mediators of Inflammation 2020, pages 1-6.
Crossref
Gaëlle Clavel, Eric Gabison & Luca Semerano. (2019) Corneal and scleral involvement in inflammatory rheumatic disease: Rheumatologists and ophthalmologists exchanging views. Joint Bone Spine 86:6, pages 699-705.
Crossref
Gaëlle Clavel, Eric Gabison & Luca Semerano. (2019) Les atteintes cornéo-sclérales des rhumatismes inflammatoires : regards croisés du rhumatologue et de l’ophtalmologue. Revue du Rhumatisme 86:4, pages 350-357.
Crossref
Dong Hyun LeeJae Yong HanJae Jun ParkJae Hee CheonMin Kim. (2019) Ophthalmologic Manifestation of Inflammatory Bowel Disease: A Review. The Korean Journal of Gastroenterology 73:5, pages 269.
Crossref
Sean Fine, Judy Nee, Pranjal Thakuria, Brian Duff, Francis A. Farraye & Samir A. Shah. (2017) Ocular, Auricular, and Oral Manifestations of Inflammatory Bowel Disease. Digestive Diseases and Sciences 62:12, pages 3269-3279.
Crossref
Maxwell S. StemBozho TodorichLisa J. Faia. (2017) Ocular Pharmacology for Scleritis: Review of Treatment and a Practical Perspective. Journal of Ocular Pharmacology and Therapeutics 33:4, pages 240-246.
Crossref
Ramana S. Moorthy & Shailaja Valluri. 2017. Peripheral Ulcerative Keratitis. Peripheral Ulcerative Keratitis 129 140 .
Lola E. Lawuyi & Avinash Gurbaxani. (2016) Refractory necrotizing scleritis successfully treated with adalimumab. Journal of Ophthalmic Inflammation and Infection 6:1.
Crossref
Jared E. Knickelbein, Karen R. Armbrust, Meredith Kim, H. Nida Sen & Robert B. Nussenblatt. 2017. Pharmacologic Therapy of Ocular Disease. Pharmacologic Therapy of Ocular Disease 231 268 .
. (2015) Adalimumab/infliximab/methotrexate. Reactions Weekly 1563:1, pages 19-19.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.